Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

XGEVA for Prostate cancer metastatic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 25 adverse event reports in the FDA FAERS database where XGEVA was used for Prostate cancer metastatic.

Most Reported Side Effects for XGEVA

Side Effect Reports % Deaths Hosp.
Death 309 29.7% 309 24
Osteonecrosis of jaw 159 15.3% 5 14
Investigation 115 11.0% 11 115
Hospitalisation 77 7.4% 4 77
Hypocalcaemia 48 4.6% 7 34
Metastases to bone 30 2.9% 3 2
Pain 28 2.7% 2 9
Pain in extremity 17 1.6% 1 5
Dyspnoea 16 1.5% 5 9
Disease progression 15 1.4% 6 4
Terminal state 14 1.3% 0 2
Back pain 13 1.3% 0 2
Fatigue 13 1.3% 1 4
Hypoaesthesia 13 1.3% 5 6
Malaise 13 1.3% 2 6

Other Indications for XGEVA

Metastases to bone (412) Prophylaxis (385) Product used for unknown indication (349) Prostate cancer (32) Breast cancer metastatic (24) Breast cancer (23) Bone disorder (7) Osteoporosis (6) Neoplasm malignant (5)

Other Drugs Used for Prostate cancer metastatic

ABIRATERONE (3,535) ENZALUTAMIDE (3,171) SIPULEUCEL-T (2,563) LEUPROLIDE (1,109) DOCETAXEL (1,102) PREDNISONE (1,082) APALUTAMIDE (659) DENOSUMAB (575) CABAZITAXEL (451) RADIUM RA-223 DICHLORIDE (445)

Related Pages

XGEVA Full Profile All Prostate cancer metastatic Drugs XGEVA Demographics XGEVA Timeline